Challenges and opportunities for development of an AIDS vaccine : AIDSNABEL, Gary J.Nature (London). 2001, Vol 410, Num 6831, pp 1002-1007, issn 0028-0836Article

A Specific Domain of the Chikungunya Virus E2 Protein Regulates Particle Formation in Human Cells: Implications for Alphavirus Vaccine DesignAKAHATA, Wataru; NABEL, Gary J.Journal of virology. 2012, Vol 86, Num 16, pp 8879-8883, issn 0022-538X, 5 p.Article

Comparative immunogenicity of human immunodeficiency virus particles and corresponding polypeptides in a DNA vaccineAKAHATA, Wataru; YANG, Zhi-Yong; NABEL, Gary J et al.Journal of virology. 2005, Vol 79, Num 1, pp 626-631, issn 0022-538X, 6 p.Article

VaccinesDOUEK, Daniel C; NABEL, Gary J.Immunological reviews. 2011, Vol 239, issn 0105-2896, 269 p.Serial Issue

Prospects for prophylactic and therapeutic vaccines against the hepatitis C virusesHOUGHTON, Michael.Immunological reviews. 2011, Vol 239, pp 99-108, issn 0105-2896, 10 p.Article

Enhanced breadth of CD4 T-cell immunity by DNA prime and adenovirus boost immunization to human immunodeficiency virus env and gag immunogensLAN WU; KONG, Wing-Pui; NABEL, Gary J et al.Journal of virology. 2005, Vol 79, Num 13, pp 8024-8031, issn 0022-538X, 8 p.Article

Adenovirus vector-based vaccines for human immunodeficiency virus type 1BAROUCH, Dan H; NABEL, Gary J.Human gene therapy. 2005, Vol 16, Num 2, pp 149-156, issn 1043-0342, 8 p.Article

Antibodies and resistance to natural HIV infectionNABEL, Gary J; SULLIVAN, Nancy J.The New England journal of medicine. 2000, Vol 343, Num 17, pp 1263-1265, issn 0028-4793Article

Smallpox vaccines: targets of protective immunityMOSS, Bernard.Immunological reviews. 2011, Vol 239, pp 8-26, issn 0105-2896, 19 p.Article

HIV vaccine strategiesNABEL, Gary J.Vaccine. 2002, Vol 20, Num 15, pp 1945-1947, issn 0264-410XConference Paper

Report of the Cent Gardes HIV Vaccine Conference: The B-cell response to HIV Part 2: Non-neutralizing antibodies Fondation Mérieux Conference Center, Veyrier du Lac, France 5-7 November 2012GIRARD, Marc P; PICOT, Valentina; LONGUET, Christophe et al.Vaccine. 2013, Vol 31, Num 29, pp 2984-2987, issn 0264-410X, 4 p.Article

The design and evaluation of HIV-1 vaccinesSAUNDERS, Kevin O; RUDICELL, Rebecca S; NABEL, Gary J et al.AIDS (London). 2012, Vol 26, Num 10, pp 1293-1302, issn 0269-9370, 10 p.Article

Report of the Cent Gardes HIV Vaccine Conference the B-cell Response to HIV. Part 1: Broadly Neutralizing Antibodies Fondation Mérieux Conference Center, Veyrier du Lac, France, 5-7 November 2012GIRARD, Marc P; PICOT, Valentina; LONGUET, Christophe et al.Vaccine. 2013, Vol 31, Num 29, pp 2979-2983, issn 0264-410X, 5 p.Article

DNA vaccines: an historical perspective and view to the futureLIU, Margaret A.Immunological reviews. 2011, Vol 239, pp 62-84, issn 0105-2896, 23 p.Article

Biological challenges and technological opportunities for respiratory syncytial virus vaccine developmentGRAHAM, Barney S.Immunological reviews. 2011, Vol 239, pp 149-166, issn 0105-2896, 18 p.Article

Immunogenomics and systems biology of vaccinesBUONAGURO, Luigi; PULENDRAN, Bali.Immunological reviews. 2011, Vol 239, pp 197-208, issn 0105-2896, 12 p.Article

Immunization delivered by lentiviral vectors for cancer and infectious diseasesHU, Biliang; TAI, April; PIN WANG et al.Immunological reviews. 2011, Vol 239, pp 45-61, issn 0105-2896, 17 p.Article

Cellular localization and function of Fas ligand (CD95l) in tumorsKUROOKA, Masayuki; NUOVO, Gerard J; CALIGIURI, Michael A et al.Cancer research (Baltimore). 2002, Vol 62, Num 5, pp 1261-1265, issn 0008-5472Article

Progress and novel strategies in vaccine development and treatment of anthraxCHITLARU, Theodor; ALTBOUM, Zeev; REUVENY, Shaul et al.Immunological reviews. 2011, Vol 239, pp 221-236, issn 0105-2896, 16 p.Article

The ERK mitogen-activated protein kinase pathway contributes to ebola virus glycoprotein-induced cytotoxicityZAMPIERI, Carisa A; FORTIN, Jean-Francois; NOLAN, Garry P et al.Journal of virology. 2007, Vol 81, Num 3, pp 1230-1240, issn 0022-538X, 11 p.Article

Development of a preventive vaccine for Ebola virus infection in primatesSULLIVAN, Nancy J; SANCHEZ, Anthony; ROLLIN, Pierre E et al.Nature (London). 2000, Vol 408, Num 6812, pp 605-609, issn 0028-0836Article

Living in a house of cards: re-evaluating CD8⁺ T-cell immune correlates against HIVMAKEDONAS, George; BETTS, Michael R.Immunological reviews. 2011, Vol 239, pp 109-124, issn 0105-2896, 16 p.Article

Generation of synthetic severe acute respiratory syndrome coronavirus pseudoparticles: Implications for assembly and vaccine productionYUE HUANG; YANG, Zhi-Yong; KONG, Wing-Pui et al.Journal of virology. 2004, Vol 78, Num 22, pp 12557-12565, issn 0022-538X, 9 p.Article

Prime-Boost Interval Matters: A Randomized Phase 1 Study to Identify the Minimum Interval Necessary to Observe the H5 DNA Influenza Vaccine Priming EffectLEDGERWOOD, Julie E; ZEPHIR, Kathryn; MASCOLA, John R et al.The Journal of infectious diseases. 2013, Vol 208, Num 3, pp 418-422, issn 0022-1899, 5 p.Article

Page / 4